ORVIA DX is a biotechnology company specializing in advanced diagnostic solutions. The vendor focuses on developing innovative tools and technologies for the early detection and monitoring of diseases, particularly in the fields of oncology and infectious diseases. ORVIA DX aims to enhance patient outcomes through precision medicine and data-driven insights, leveraging cutting-edge research and development to deliver reliable and efficient diagnostic products.